NAD+ × evolvebiopep.com — lab test, January 2026
Vanguard Laboratory publishes a public verification portal. Any test attributed to this lab can be looked up and confirmed directly with the lab — so this result doesn't rest on our review alone.
This certificate carries no lookup code.
Test results
This is a purity and identity analysis. Sterility, endotoxins, and heavy metals were not screened — a high purity figure says nothing about those.
About this test
Label 500 mg · Lab measured 372.14 mg
74% of label, basis not stated — shown as printed. Reconstituted with 2 mL, a 50-unit draw holds 93 mg using the measured mass, against 125 mg on the label — 26% less.
One vial from this lot was weighed by the laboratory, not yours. This page reports what the certificate says; it does not recommend a dose.
Independent HPLC purity analysis of NAD+ from evolvebiopep.com, performed by Vanguard Laboratory on January 26, 2026. Reported purity: 99.8%. Net content: 372.14 mg against 500 mg labeled (74% of label). Tested content is 26% below the labeled amount. Endotoxins: <0.03 EU/mg. Batch N500126. Sample source: shop-provided. Certificate of analysis attached.
Certificate of analysis
Other lots of NAD+ from evolvebiopep.com
| Lot | Tested | Lab | Purity | vs label | Status |
|---|---|---|---|---|---|
| EN-260512-B500 | 21 May 2026 | Ethos Analytics | 99% | 103% | Lab has no portal |
| N0326P | 26 Mar 2026 | Ethos Analytics | 98% | 110% | Lab has no portal |
Batches this shop has published a certificate for, newest first. A lot whose printed value cannot identify a batch is not listed.
Have you tested this peptide?
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.
Community discussion